3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

Suppliers

Names

[ CAS No. ]:
602-52-8

[ Name ]:
3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

[Synonym ]:
Novidium chloride
homidium chloride
Ethidium chloride
Phenanthridinium,3,8-diamino-5-ethyl-6-phenyl chloride
3,8-Diamino-5-ethyl-6-phenylphenanthridinium chloride
Babidium chloride
2,7-Diamino-9-phenyl-10-ethylphenanthridinium chloride
EINECS 210-018-2
[3H]-Ethidium

Chemical & Physical Properties

[ Molecular Formula ]:
C21H20ClN3

[ Molecular Weight ]:
349.85700

[ Exact Mass ]:
349.13500

[ PSA ]:
55.92000

[ LogP ]:
2.29820

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SF7960000
CHEMICAL NAME :
Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, chloride
CAS REGISTRY NUMBER :
602-52-8
LAST UPDATED :
199606
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C21-H20-N3.Cl
MOLECULAR WEIGHT :
349.89
WISWESSER LINE NOTATION :
T B666 HKJ EZ H2 IR& LZ &Q &G

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
21 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
REFERENCE :
NCINS* National Cancer Institute Report. (Bethesda, MD 20014) Volume(issue)/page/year: -,107,1965
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCINS* National Cancer Institute Report. (Bethesda, MD 20014) Volume(issue)/page/year: -,107,1965
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
56370 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
14 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
REFERENCE :
NCINS* National Cancer Institute Report. (Bethesda, MD 20014) Volume(issue)/page/year: -,107,1965 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
17640 ug/kg/28D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - chronic pulmonary edema Skin and Appendages - dermatitis, other (after systemic exposure) Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCINS* National Cancer Institute Report. (Bethesda, MD 20014) Volume(issue)/page/year: -,107,1965
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
17640 ug/kg/28D-I
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea Skin and Appendages - dermatitis, other (after systemic exposure) Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NCINS* National Cancer Institute Report. (Bethesda, MD 20014) Volume(issue)/page/year: -,107,1965

Precursor & DownStream

Precursor

DownStream

  • Isometamidium chloride hydrochloride

Related Compounds

  • ethidium
  • 3,8-Diamino-5-ethyl-6-methylphenanthridinium bromide
  • 3,8-diamino-5-ethyl-6-phenylphenanthridin-5-ium-2-ol
  • Ethidium bromide
  • Phenanthridinium, 3,8-diamino-5-ethyl-6-methyl-
  • 3,8-diamino-5-methyl-6-phenylphenanthridinium bromide dihydrobromide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 1-[(Tert-butoxy)carbonyl]-5-ethylpyrrolidine-2-carboxylic acid
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • 3-(8-Amino-3-methyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)propanoic acid
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine